Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) shed 4.43% to $11.86 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.76% to 10,931.67 and the Dow Jones Industrial Average rising 0.80% to 33,973.01. The stock's fall snapped a two-day winning streak. Novavax Inc. closed $123.83 short of its 52-week high ($135.69), which the company achieved on January 12th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) fell 0.16% to $174.88, Pfizer Inc. (PFE) fell 0.36% to $47.45, and Merck & Co. Inc. (MRK) rose 0.23% to $111.07. Trading volume (6.0 M) remained 689,606 below its 50-day average volume of 6.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 11, 2023.
(END) Dow Jones Newswires
January 11, 2023 17:15 ET (22:15 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.